| 产品名称: | Human Coxsackievirus A 17 |
|---|---|
| 商品货号: | TS183267 |
| Classification: | Picornaviridae, Enterovirus, Human enterovirus C |
| Deposited As: | Coxsackievirus A17 |
| Agent: | Human Coxsackievirus A 17 |
| Strain: | G-12 |
| Applications: | Produces degeneration of muscle with loss of striation and hyaline changes. Produces degeneration of muscle with loss of striation and hyaline changes. |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation: | feces from 3-year-old male, South Africa, 1951 |
| Product Format: | frozen |
| Storage Conditions: | xa0 -60°C |
| Comments: | Produces degeneration of muscle with loss of striation and hyaline changes. Produces degeneration of muscle with loss of striation and hyaline changes. |
| Effect on Host: | Yes, in vivo effects: Flaccid paralysis Flaccid paralysis |
| Name of Depositor: | NIH/NIAID |
| Source: | feces from 3-year-old male, South Africa, 1951 |
| Year of Origin: | 1951 |
| References: | Gear JH. Poliomyelitis. Papers and discussions presented at the Second International Poliomyelitis Conference. Philadelphia, PA: Lippincott; 1952. |